Celsion (CLSN) Granted IRB Approval to Commence Clinical Study of ThermoDox Plus High Intensity Focused Ultrasound

June 20, 2019 8:33 AM EDT Send to a Friend
Celsion Corporation (NASDAQ: CLSN), an oncology drug-development company, announces that the University Medical Center Utrecht in the Netherlands has received ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login